The nature of work continues to change at lightning speed. First off, workers — both clinicians and non-clinicians — now need to be able to access key applications from anywhere on both company-issued and personal devices. Secondly, the apps being accessed are often no-longer in tightly…
Source: healthsystemcio.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
